2 exciting ETFs named as buys by experts

Here are two ETFs that could be buys…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're wanting to buy some exchange traded funds (ETFs), then you certainly have a lot of options.

But which ones could be buys? Two that have been tipped as buys by analysts are listed below. Here's what they are saying about them:

A young woman sits with her hand to her chin staring off to the side thinking about her investments.

Image source: Getty Images

ETFS Battery Tech & Lithium ETF (ASX: ACDC)

If you're wanting to get some exposure to the decarbonisation megatrend, then the ETFS Battery Tech & Lithium ETF could be one way to do it.

This popular ETF allows investors to buy a slice of companies involved in battery technology, electric vehicles, and lithium mining. This includes BYD, Mineral Resources Limited (ASX: MIN), Pilbara Minerals Ltd (ASX: PLS), Nissan, and Renault.

Jessica Amir from Saxo Markets is positive on the ETF. Especially for investors that aren't keen on stock picking in the lithium sector. She commented:

If stock picking is not for you, and if you believe, like we do, that the electric vehicle industry and the critical minerals/ commodities will continue to see rising demand, and policy support, and also benefit from the world striving to be carbon neutral by 2050, then you could invest or trade in Global X Lithium & Battery Tech ETF (LIT) or ETFS Battery Tech & Lithium ETF (ACDC) that invests in about 30 of the biggest EV and battery technology companies in the world.

ETFS S&P Biotech ETF (ASX: CURE)

Another ETF that has been tipped as a buy is the ETFS S&P Biotech ETF. As its name implies, this ETF gives investors access to U.S. healthcare biotechnology companies.

The fund manager notes that these companies are engaged in the research, development and manufacturing of products based on genetic analysis and genetic engineering. This includes the development of immunotherapy treatments and vaccines to treat human diseases.

Among its largest holdings are ChemoCentryx, Global Blood Therapeutics, and Twist Bioscience.

Felicity Thomas from Shaw & Partners is a fan of the ETF. She recently told Livewire:

I like to buy ETFs for the long term. We have an ageing population, and what's the most important thing in the world? Your health. Biotech, healthcare, and life sciences, that's where you want to be invested over the next couple of decades.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ETFs

A tech worker wearing a mask holds a computer chip.
ETFs

The growing case for this semiconductor ASX ETF

Why there's long-term upside for this fund.

Read more »

A senior investor wearing glasses sits at his desk and works on his ASX shares portfolio on his laptop.
ETFs

Why ASX mid-cap shares are finally about to have their moment: Expert

Here's how to target mid-cap companies.

Read more »

wind farm
ETFs

Why this ASX ETF could be the simplest way to play the global clean energy boom

Here is how Australian investors can get diversified exposure to the companies leading the green transition.

Read more »

ETFs

3 ASX ETFs I'd buy to build a portfolio from scratch

With just a few ASX ETFs, investors can gain exposure to different countries, sectors, and investment styles.

Read more »

A share market investment manager monitors share price movements on his mobile phone and laptop
ETFs

3 excellent ASX ETFs to watch in June

These funds offer investors an easy way to invest in different parts of the share market.

Read more »

A woman gazes with anticipation into a glass ball she's holding in her hands.
ETFs

Is it time to buy the Vanguard Australian Shares ETF?

For investors wanting a simple, low-fuss way to invest in Australian shares, this ETF remains one of my favourite options.

Read more »

the words ETF in red with rising block chart and arrow
ETFs

Which ASX ETFs I'd buy for retirement investing

I’m a big fan of these two exchange-traded funds.

Read more »

A young woman drinking coffee in a cafe smiles as she checks her phone.
ETFs

Why this ASX ETF could be the simplest way to own Australia's 200 best businesses

One trade and zero stock picking. Here's the case for making this ASX ETF the core of your Australian shares…

Read more »